Email Alert | RSS    帮助

中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (3): 272-275.doi: 10.3969/j.issn.1000-6621.2020.03.017

• 论著 • 上一篇    下一篇

2016年广东省涂阴培阳肺结核患者耐药情况分析

陈燕梅,黄新春,孙琦,张晨晨,温文沛,陈亮()   

  1. 510630 广州,广东省结核病控制中心
  • 收稿日期:2019-10-09 出版日期:2020-03-10 发布日期:2020-03-18
  • 通信作者: 陈亮 E-mail:18928929722@126.com
  • 基金资助:
    “十三五”国家科技重大专项(2018ZX10715004-002、2018ZX10722301-004-004)

Analysis of drug resistance in patients with smear-negative and culture-positive pulmonary tuberculosis in Guangdong province in 2016

CHEN Yan-mei,HUANG Xin-chun,SUN Qi,ZHANG Chen-chen,WEN Wen-pei,CHEN Liang()   

  1. Center for Tuberculosis Control of Guangdong Province, Guangzhou 510630, China
  • Received:2019-10-09 Online:2020-03-10 Published:2020-03-18
  • Contact: Liang CHEN E-mail:18928929722@126.com

摘要:

目的 了解广东省涂阴培阳肺结核患者的耐药情况。方法 收集广东省2016年1—12月32个结核病耐药监测点12323例临床确诊的初治涂阴肺结核患者作为研究对象,均进行了分枝杆菌培养检测,其中1224例阳性,涂阴培阳率为9.9%。经菌种鉴定,1177例(96.16%)为结核分枝杆菌复合群,47例(3.84%)为非结核分枝杆菌。对确定为结核分枝杆菌复合群的1177株菌株进行异烟肼(INH)、链霉素(Sm)、利福平(RFP)、乙胺丁醇(EMB)、卡那霉素(Km)、氧氟沙星(Ofx)、卷曲霉素(Cm)、丙硫异烟胺(Pto)、对氨基水杨酸(PAS)等9种药物的药物敏感性试验(简称“药敏试验”)。结果 12323例初治涂阴肺结核患者进行培养,涂阴培阳肺结核患者总耐药率为29.57%(348/1177),耐多药率为2.38%(28/1177),广泛耐药率为0.08%(1/1177),单耐药率为17.42%(205/1177),多耐药率为9.77%(115/1177)。男性耐多药率(2.94%,25/849)高于女性(0.91%,3/328),差异有统计学意义(χ 2=4.20,P=0.040)。多耐药谱有52种类型,其中耐INH+Sm者最多,占20.87%(24/115);其次为耐Sm+Km者(9.57%,11/115)。结论 广东省涂阴培阳肺结核患者有较高的耐药率,应加强监测与管理,减少耐药结核病的发生。

关键词: 分枝杆菌, 结核, 集落计数, 微生物, 抗药性, 细菌, 微生物敏感性试验

Abstract:

Objective This study aimed to investigate the drug resistance status of patients with smear-negative while culture-positive pulmonary tuberculosis (PTB) in Guangdong province. Methods A total of 12323 newly diagnosed smear-negative PTB patients from 32 tuberculosis drug resistance surveillance sites in Guangdong province during January-December 2016 were collected as research subjects. After sputum culture, 1224 were culture positive, with culture positive rate of smear-negative of 9.9%. The results of strain identification tests indicated that 1177 cases (96.16%) were Mycobacterium tuberculosis complex, and 47 cases (3.84%) were nontuberculous mycobacteria (NTM). Then, drug sensitivity tests were performed on 1177 strains identified as Mycobacterium tuberculosis complex with 9 different anti-TB drugs, which were isoniazid (INH), streptomycin (Sm), rifampicin (RFP), ethambutol (EMB), kanamycin (Km), ofloxacin (Ofx), capriomycin (Cm), propionamide (Pto) and p-aminosalicylic acid (PAS). Results Totally, 12323 sputum isolates from newly diagnosed patients with smear-negative PTB were cultured, and the results showed that the total resistance rate was 29.57% (348/1177), including a multidrug resistance (MDR) rate of 2.38% (28/1177), extensive drug resistance (XDR) rate of 0.08% (1/1177), single drug resistance rate of 17.42% (205/1177), and a polyresistance rate of 9.77% (115/1177). We also found that the MDR rate (2.94%, 25/849) in men were significantly higher than those in women (0.91%, 3/328), with significant statistical differences (χ 2=4.19, P=0.040). There were 52 types of MDR spectrum, among which, INH+Sm resistant types were the most, accounting for 20.87% (24/1150, followed by Sm+Km resistant types, accounting for 9.57% (11/115). Conclusion Patients with smear-negative and culture-positive PTB in Guangdong province have a higher drug resistance rate. Monitoring and management should be strengthened to reduce the occurrence of drug-resistant tuberculosis.

Key words: Mycobacterium tuberculosis, Colony count, microbial, Drug resistance, bacterial, Microbial sensitivity tests